Ambrx Biopharma, Inc.
Related Filers (18)
- HOPU Reunion Co Ltd (6)
- Ambrx Biopharma Cayman, Inc. (4)
- JOHNSON & JOHNSON (4)
- Nelson Sonja (3)
- O'Connor Daniel J. (3)
- Cormorant Asset Management, LP (2)
- Deep Track Capital, LP (2)
- Cormorant Private Healthcare Fund III LP (1)
- Chen Bihua (1)
- Cormorant Global Healthcare Master Fund, LP (1)
- Nextech Crossover I GP S.a r.l. (1)
- Aromando Andrew (1)
- WuXi PharmaTech Healthcare Fund I L.P. (1)
- FMR LLC (1)
- Venrock Healthcare Capital Partners III, L.P. (1)
- Paradigm Biocapital Advisors LP (1)
- D. E. SHAW & CO, L.P. (1)
- COMMODORE CAPITAL LP (1)
- Show More ...
News (5)
8-K
Monday, 1/8/2024
Current report filing
8-K
Friday, 12/1/2023
Current report filing
8-K
Monday, 10/23/2023
Current report filing
8-K
Monday, 10/16/2023
Current report filing
8-K12G3
Thursday, 10/12/2023
Notification that a class of securities of successor issuer is deemed to be registered pursuant to Section 12(g)
Other (12)
144
Tuesday, 12/26/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 12/19/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 12/8/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 12/5/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 12/1/2023
Filing for proposed sale of securities under Rule 144
EFFECT
Thursday, 11/2/2023
Notice of Effectiveness
CORRESP
Wednesday, 11/1/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
144
Wednesday, 11/1/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 10/27/2023
Filing for proposed sale of securities under Rule 144
CORRESP
Wednesday, 10/25/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Friday, 9/15/2023
Notice of Effectiveness
CORRESP
Wednesday, 9/13/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Ownership (17)
SC 13G/A
Wednesday, 2/14/2024
COMMODORE CAPITAL LP: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Deep Track Capital, LP: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Cormorant Asset Management, LP: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Paradigm Biocapital Advisors LP: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
D. E. SHAW & CO, L.P.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Venrock Healthcare Capital Partners III, L.P.: Major Shareholders
SC 13G/A
Monday, 2/12/2024
HOPU Reunion Co Ltd: Major Shareholders
SC 13G/A
Friday, 2/9/2024
FMR LLC: Major Shareholders
SC 13G/A
Monday, 2/5/2024
WuXi PharmaTech Healthcare Fund I L.P.: Major Shareholders
4
Monday, 12/11/2023
Aromando Andrew: Statement of changes in beneficial ownership of securities
4
Monday, 12/11/2023
Nelson Sonja: Statement of changes in beneficial ownership of securities
4
Monday, 12/11/2023
O'Connor Daniel J.: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 11/2/2023
Nextech Crossover I GP S.a r.l.: Major Shareholders
SC 13G
Thursday, 11/2/2023
Deep Track Capital, LP: Major Shareholders
4
Tuesday, 10/31/2023
O'Connor Daniel J.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/31/2023
Nelson Sonja: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/25/2023
Cormorant Asset Management, LP: Statement of changes in beneficial ownership of securities
Prospectus (9)
S-3
Tuesday, 10/17/2023
Registration statement for specified transactions by certain issuers
S-8
Thursday, 10/12/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8 POS
Thursday, 10/12/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Thursday, 10/12/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Thursday, 10/12/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Thursday, 10/12/2023
Post-effective amendment to a S-8 registration statement
424B3
Friday, 9/15/2023
Prospectus filed pursuant to Rule 424(b)(3)
S-4/A
Tuesday, 9/12/2023
Registration of securities issued in business combination transactions
S-4
Friday, 8/25/2023
Registration of securities issued in business combination transactions
Proxies (7)
DFAN14A
Thursday, 2/15/2024
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Monday, 1/29/2024
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DEFM14A
Monday, 1/29/2024
Definitive proxy statement relating to a merger, acquisition, or disposition
PREM14A
Friday, 1/19/2024
Preliminary proxy statement relating to a merger, acquisition, or disposition
DFAN14A
Tuesday, 1/9/2024
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DEFA14A
Monday, 1/8/2024
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DFAN14A
Monday, 1/8/2024
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material